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Abstract
Background: Stigma, criminalisation and a lack of data on drug use contribute to the “invisibility” of people who
inject drugs (PWID) and make HIV prevention and treatment service delivery challenging. We aimed to confirm
locations where PWID congregate in Cape Town, eThekwini and Tshwane (South Africa) and to estimate PWID
population sizes within selected electoral wards in these areas to inform South Africa’s first multi-site HIV prevention
project for PWID.
Methods: Field workers (including PWID peers) interviewed community informants to identify suspected injecting
locations in selected electoral wards in each city and then visited these locations and interviewed PWID. Interviews
were used to gather information about the accessibility of sterile injecting equipment, location coordinates and
movement patterns. We used the Delphi method to obtain final population size estimates for the mapped wards
based on estimates from wisdom of the crowd methods, the literature and programmatic data.
Results: Between January and April 2015, we mapped 45 wards. Tshwane teams interviewed 39 PWID in 12 wards,
resulting in an estimated number of accessible PWID ranging from 568 to 1431. In eThekwini, teams interviewed 40
PWID in 15 wards with an estimated number of accessible PWID ranging from 184 to 350. The Cape Town team
interviewed 61 PWID in 18 wards with an estimated number of accessible PWID ranging between 398 and 503.
Sterile needles were only available at one location. Almost all needles were bought from pharmacies. Between 80
and 86% of PWID frequented more than one location per day. PWID who reported movement visited a median of
three locations a day.
Conclusions: Programmatic mapping led by PWID peers can be used effectively to identify and reach PWID and
build relationships where access to HIV prevention commodities for PWID is limited. PWID reported limited access
to sterile injecting equipment, highlighting an important HIV prevention need. Programmatic mapping data show
that outreach programmes should be flexible and account for the mobile nature of PWID populations. The PWID
population size estimates can be used to develop service delivery targets and as baseline measures.
Keywords: Formative assessment, People who inject drugs, Harm reduction, HIV, South Africa, Population size
estimation, Programmatic mapping
* Correspondence: andrew.scheibe@gmail.com
1TB/HIV Care Association, Cape Town, South Africa
2Desmond Tutu HIV Centre, Cape Town, South Africa
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Scheibe et al. Harm Reduction Journal  (2017) 14:35 
DOI 10.1186/s12954-017-0164-z
Background
“After 30 years the time for dealing with injecting drug
use has finally come,” proclaimed Dr. Fareed Abdullah,
the then Chief Executive Officer, South African National
AIDS Council. This address at the South African Drug
Use and HIV Preconference in 2015 highlighted the
dearth of HIV prevention services for people who inject
drugs (PWID) in South Africa [1].
Injecting drug use and HIV
PWID are at disproportionately higher risk for HIV infec-
tion and onward transmission compared to the general
population [2]. HIV is efficiently spread through the use
of contaminated injecting equipment and can spread
rapidly within PWID networks [3, 4]. PWID are also at
risk of HIV transmission through unprotected sex, which
is influenced by links to sex work and drug-related effects
on decision making [5, 6].
Several social and structural factors contribute to the
increased HIV burden among PWID. For example, the
criminalisation of drug use contributes to the marginal-
isation and social exclusion of PWID, which increases
their vulnerability and often creates barriers to effective
provision of and access to health services, particularly
in the public sector [7]. Furthermore, injecting drug use
often occurs covertly or in dangerous environments
(such as in dilapidated buildings or tunnels) and rapidly
(for fear of being arrested by the police)—indirectly in-
creasing the health-related risks of injecting through
using contaminated needles and incurring wounds
through rapid injecting practices [8]. Stigma and dis-
crimination by community members and health pro-
viders contribute to delayed health-seeking behaviours
among PWID [9]. Furthermore, a lack of appropriate
HIV prevention, treatment, care and support services
contribute to the HIV burden and risk of onward HIV
transmission among PWID, their sexual and drug-using
partners and the broader population [10]. Limited data
on injecting drug practices, particularly in Africa, con-
tribute to the populations’ “invisibility” [11]. The social
and structural factors that increase the risk of HIV
among PWID are important in the African context
where the HIV prevalence is high, and access to
evidence-based interventions is limited.
Injecting drug use and HIV in South Africa
Drug use is criminalised in South Africa, but no laws pro-
hibit the purchase or provision of injecting equipment.
South Africa’s national PWID population size is measured
by a modelling study using information from the 2008
South African household survey data; this study estimates
that there are 67,000 PWID in South Africa [12]. Sub-
national or city-specific estimates do not exist, limiting
the ability to appropriately plan and provide services for
PWID. However, local research has identified the use of
contaminated injecting equipment, unprotected sex, sex
work and low levels of HIV and drug-related knowledge
among PWID in South Africa [13–17]. In 2013, HIV
prevalence among PWID participating in a multi-city
study, including Cape Town, eThekwini and Tshwane
(n = 450) was 14% [17]. The existing data point to
high-risk practices and the potential of ongoing trans-
mission unless effective prevention interventions be-
come available.
HIV prevention and treatment services for PWID in South
Africa
Substance-use disorder treatment and HIV services for
PWID in South Africa are limited and are primarily pro-
vided by civil society organisations. Publicly funded
substance-use disorder treatment services are almost
exclusively abstinence-based (i.e., organisations that view
abstinence of drug use as the only treatment outcome
with no interventions to reduce the potential harms of
drug use). Private sector services are prohibitively expen-
sive for most PWID [17–20]. None of the existing service
providers provide the full package of evidence-based HIV
prevention, treatment and care services for PWID as rec-
ommended by the World Health Organization (WHO)/
United Nations Office on Drugs and Crime (UNODC)/
Joint United Nations Programme on HIV and AIDS
(UNAIDS) and President’s Emergency Plan for AIDS
Relief (PEPFAR). In 2016, opioid substitution therapy
(OST), a key WHO/UNODC/UNAIDS/PEPFAR-recom-
mended intervention, was only available free of charge
through one civil society organisation based in Cape
Town. The project provides OST for free for 6 months
and has provided OST to 178 people (almost exclusively
non-injecting heroin users) between 2013 and 2016 [21].
Although needle and syringe programmes are evidence-
based and are also part of the earlier mentioned WHO/
UNODC/UNAIDS/PEPFAR-recommended package, only
one programme targeting men who have sex with men
who inject drugs operated in Cape Town for a limited
period (September 2013 to November 2014) [22, 23]. In a
country with the highest HIV burden and a substantial
PWID population, it is clear that two programmes for
PWID are insufficient.
The overall goal of the programmatic mapping activity
was to prepare three sites to establish PWID HIV preven-
tion and harm reduction services. The study objectives
were to (1) map locations where PWID congregate in se-
lected electoral wards in three cities, (2) collect informa-
tion to inform the delivery of HIV prevention and harm
reduction services for PWID and (3) estimate the number
of PWID accessible at identified locations in selected
electoral wards in the selected cities.
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Methods
This study employed a modified programmatic mapping
approach [24]. An overview of the study methods are
summarised in Fig. 1.
Formative assessment team
Teams included a coordinator, field workers (including
PWID peers), data capturers, a driver and support staff. In
addition, PWID volunteers worked as guides to facilitate
links with other PWID community members. Team mem-
bers and PWID volunteers were selected based on their
understanding of the local drug-using context and interest
in being involved in the project. A central management
team oversaw the planning and implementation.
Stakeholder engagement
During the first half of 2014, the authors and repre-
sentatives from their organisations held consultation
workshops with PWID in Cape Town, eThekwini and
Tshwane. Approximately 20 PWID attended each
workshop. PWID community advisory groups (CAGs)
comprised of interested PWID were established. Par-
ticipants were reimbursed for their transport to the
workshop and CAGs (ZAR 40 (US$2.91) and ZAR60
(US$4.36),1 respectively). In early 2014, we conducted
stakeholder workshops with representatives from law
enforcement agencies, health and substance-use dis-
order treatment providers, government representatives
and other stakeholders. These workshops led to stron-
ger relationships with the PWID community and other
stakeholders, which allowed successful study imple-
mentation and later service delivery.
Ward selection
Study staff mapped locations where PWID were thought
to congregate onto large city maps. These maps included
electoral ward boundaries that are outlined by South
Africa’s municipal demarcation board [25]. Each site team
developed a list of wards to be mapped. Wards were
ranked by the number of suspected PWID locations in
each ward, which was informed by the earlier consulta-
tions. The number of wards (18 in Cape Town, 16 in
eThekwini and 12 in Tshwane) was determined by team
size, budget and timeframe.
Training
Study teams were trained on the methodology of the for-
mative assessment, personal safety, ethical research practice
and human subjects’ protection, engagement strategies,
data entry and quality control over a period of 3 days.
Training included didactic lectures, interactive sessions and
role-plays.
Fieldwork
In December 2015, we piloted tools and fieldwork activ-
ities in wards not selected for formal mapping. Formative
assessment teams met at the beginning of the day to plan
activities and at the end of the day to discuss outcomes
and challenges. Site teams engaged with the central man-
agement team each week. Teams reflected on the various
stages of the formative assessment, including successes
Fig. 1 Overview of formative assessment methodology
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and challenges; these reflections were used to inform plan-
ning for service delivery and engagement with the PWID
community and stakeholders. Fieldwork included location
identification (LI), location verification (LV) and location
validation activities.
Location identification
Working in pairs, fieldworkers conducted up to 20 brief
interviews per day with secondary key informants (com-
munity members who were not drug users) in selected
wards. Secondary key informants were chosen because
they had some level of engagement or knowledge of
drug use in their community. The type of secondary key
informants approached were identified as part of earlier
consultation processes and included street vendors, taxi
drivers, shop keepers and law enforcement officers.
Interviews lasted approximately 10 min each. After
introducing themselves, team members described the ra-
tionale, objectives and nature of the brief interview and
the study, provided interviewees with an information
sheet and answered questions before asking for verbal
informed consent. Interviews were undertaken in local
languages (i.e. English, Afrikaans, isiZulu, Setswana and
isiXhosa). Fieldworkers started by asking secondary key
informants “what the situation with drug use was like in
the area” and “where can people who use drugs be
found?” Locations included places where PWID (i)
bought, sold and/or used drugs; (iii) engaged in income
generating activities; (iii) socialised and (iv) slept. Field-
workers then probed for names and addresses of these
locations. Additional questions were asked about each
location (e.g. the number of people who use drugs at
these locations and their sex and whether injecting drug
use occurred at these locations). Participants were of-
fered condoms and lubricants once the interview was
completed. HIV risk reduction counselling was provided
where possible and appropriate. Fieldworkers recon-
vened at the end of each day to collate data and to gen-
erate lists of locations.
Location verification
Fieldworkers visited all locations that were identified by
at least one secondary key informant as being a location
where PWID possibly congregate. Fieldworkers re-
corded location coordinates of all locations visited
using a global positioning system (GPS) device. At each
location, fieldworkers attempted to identify and engage
with an injecting drug user (primary key informant).
Additional information about the location and visibility
of HIV prevention commodities (unused condoms,
sealed lubricant and unused injecting equipment) was
recorded. Verification interviews lasted approximately
10 min each and followed a similar format to the loca-
tion identification process (i.e. introduction, project
overview, verbal consent and specific questions). Outreach
teams revisited sites up to three times if a primary key in-
formant was not identified, but injecting equipment was
visible or a non-injecting drug user confirmed that PWID
had been seen at that location. PWID interviews covered
details of (1) the location (busiest time, number and types
of PWID that congregate there, location of nearest clinic,
access to condoms and lubricants, needle and syringe ac-
cess and disposal, drug sales, sex work and experiences
with law enforcement); (2) mobility (average number of
locations PWID meet or congregate at during one day);
(3) perceptions about whether their health needs were
being met; and (4) details of other locations where PWID
congregate.
Location validation
The research team visited a subset2 of locations that were
identified by secondary key informants as locations where
people use (but not inject) drugs to assess underestima-
tion of PWID locations. Validation visits followed the
location verification procedures, and efforts were made to
identify and interview PWID.
Results validation
Fieldwork findings were presented to the PWID CAGs
in September 2015. CAG members’ input on the find-
ings was obtained, specifically around the identified loca-
tions, average numbers of estimated PWID at identified
locations and PWID movement.
Data analysis, mapping and size estimation
Data analysis
Data from the location identification and verification
forms were entered into a password-protected excel
spreadsheet. Data was then imported into Stata (version
11.0, STAT Corp., College Station, Texas, USA) for ana-
lysis. We calculated measures of central tendency and
dispersion for numerical variables and used frequency
tables to explore categorical data.
Geospatial mapping
We exported GPS coordinates of suggested PWID loca-
tions into an excel spreadsheet. These GPS coordinates
and details about location type (i.e. whether or not PWID
were interviewed) were entered into QGIS (version 2.6.1
Brighton). Finally, we mapped the locations that were
visited graphically to inform outreach service delivery
routes. To ensure confidentiality and to safeguard PWID
communities included in the mapping, no location details
are presented in this manuscript.
Size estimation
We developed six PWID estimates using different methods:
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1. ‘Location verification estimates’ reflected data collected
during location verification and location validation
processes as per a formula adapted from previous
programmatic mapping studies, which take PWID
movement into account [24] (see Fig. 2).
2. ‘CAG revised location verification finding estimates’
were revisions of the initial estimates based on input
provided by the CAGs at results validation meetings.
3. ‘CAG estimates’ are the estimates of the number
of PWID who CAGs estimated to be accessible in
the mapped wards in each city using consensus
estimation methods [26]. These were also
conducted during the result validation meetings.
4. ‘Literature estimates’ were developed for each mapped
ward. The number of people aged 18 to 64 years for
each ward (based on 2011 census data) [27] was
multiplied by 0.2%, the estimated prevalence of
injecting drug use from an earlier South African
study [12].
5. ‘Service delivery consent form estimates’ were obtained
by counting the number of PWID who had accessed
needle and syringe and other HIV prevention3
services between June and October 2015 and that
consented for service delivery data to be used.
6. ‘Service delivery contact form estimates’ were obtained
by counting the number of PWID who had accessed
needle and syringe and other HIV prevention services.
Individuals were tracked with unique participant
identification codes (recorded on outreach contact
forms) between June and October 2015.
The final population size estimate reflects an estimated
range of PWID that could be reached with HIV preven-
tion services in the mapped wards.
Quality assurance
Assessment procedures were standardised, and scripts
were developed and used for relevant study procedures.
Trained staff, fluent in local languages, completed study
activities. Research team members observed interviews
and used a standardised checklist to monitor interviews.
Ethical considerations
The University of the Western Cape (reference number
14/3/9), the KwaZulu-Natal Provincial Department of
Health (HRKM 01/15) and the United States Centers for
Disease Control and Prevention (PR 2013-38) provided
ethical approval for this study.
Results
The results of the formative assessment are provided by
city, including details of PWID locations, service delivery
needs and size estimates. An overview of formative assess-
ment participants and characteristics of the confirmed




We interviewed 399 secondary key informants (262 males,
131 females, and 6 transgender women) in 18 of Cape
Fig. 2 Formula for developing size estimates based on location verification data
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Town’s 111 electoral wards. Of the 230 suggested
PWID locations, the team visited and identified 69 lo-
cations where at least 1 PWID was present. PWID at
eight of these locations refused participation in the
study. Sixty-one PWID were interviewed at 61 locations
(56 males and 5 females). Safety concerns linked to
gang violence prevented the team from visiting 37
potential PWID locations and 4 locations selected for
location validation. Most PWID congregated in public
spaces, near bridges, parks, or on the street (61%, 37/
61). No PWID were identified at the 29 non-injecting
locations that were selected and visited as part of the
location validation process.
Service delivery needs and other location characteristics
Sterile injecting equipment was not reportedly avail-
able at any of the PWID locations. Sex work and drug
sales took place at more than half of the PWID loca-
tions (54% (33/61) and 61% (37/61), respectively).
Two-thirds of PWID (56/91) could identify nearby
health facilities, and 58 identified locations where con-
doms could be accessed. Almost all PWID (92%, 56/
61) identified pharmacies where needles and syringes
could be purchased. Less than half of PWID (38%, 23/
61) felt that their health needs were met. Breaking
used needles and then discarding them in the rubbish
bin was the most common method of needle and syr-
inge disposal (43%, 26/61). Most (84%, 51/61) PWID
visited four locations per day where other PWID con-
gregated. Law enforcement was the major cause of
PWID movement.
Population size estimate
We found that on average, seven PWID congregated at
each location at peak times. The range of PWID esti-
mated to be accessible in the 18 mapped wards, as per
final consensus, was 398 to 503 (see Fig. 3).
Table 1 Demographic characteristics of PWID interviewed and characteristics of locations where PWID congregate in selected wards
in Cape Town, Tshwane and eThekwini, 2015
Metropolitan area Cape Town Tshwane eThekwini
n n n
No. of mapped electoral wards 18 12 15a
No. of secondary key informants interviewed 400 280 385
No. locations where drug use suspected 734 146 222
No. locations where injecting suspected 230 68 164
No. locations where PWID interviewed 61 36 40
Locations where injecting is not suspected but PWID identifiedb 0/29 (0%)c 1/13 (8%) 1/14 (7%)
Median no. of people estimated to congregate at locations (interquartile range) 7 (4–15) 10 (5–13) 6 (3–11)
n (%) n (%) n (%)
Sex of PWID interviewed Male 56 (92%) 31 (86%) 35 (88%)
Female 5 (8%) 5 (14%) 5 (12%)
Race of PWID interviewed Black 3 (5%) 16 (44%) 6 (15%)
White 22 (36%) 18 (50%) 29 (73%)
Colouredd 36 (59%) 2 (6%) 1 (3%)
Indian/Asian 0 0 4 (10%)
No. of locations where commodities seen Condoms 3 (5%) 0 1 (3%)
Lubricant 2 (3%) 0 0
Sterile injecting equipment 0 0 1 (3%)
No. of locations where sterile injecting equipment reportedly available (for purchase) 3 (5%) 6 (17%) 6 (15%)
Needle and syringe disposal Discarded in bin, needle intact 26 (43%) 16 (44%) 20 (51%)
Needle broken off, then discarded in bin 11 (18%) 11 (31%) 10 (26%)
Needle discarded on the ground 11 (18%) 5 (14%) 7 (18%)
Sex work occurs at the location 33 (54%) 15 (42%) 23 (58%)
Drug sales/purchase occurs at the location 37 (61%) 26 (72%) 23 (58%)
aMapping of one ward was not possible due to social unrest
bThese locations and PWID are included in the total number of PWID interviewed and verified PWID locations
cFour locations were not visited due to violence in the area
d‘Coloured’ is a recognised South African racial group and refers to people of mixed Black/African, European and/or Asian ancestry
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Tshwane
PWID locations
We interviewed 280 non-drug users (221 males and 59
females) in 12 of Tshwane’s 105 electoral wards. Of the
90 suggested PWID locations, 37 PWID locations were
verified and one consenting PWID interviewed at each
of 35 locations. The team identified and interviewed an
additional PWID at one of the 13 non-injecting loca-
tions selected to be visited as part of the location valid-
ation process. In total, 31 male and 5 female PWID
were interviewed. Most locations (92%, 33/36) were in
public spaces, including on the street, near bridges and
around parks.
Service delivery needs and other location characteristics
Sterile injecting equipment was not reportedly available
at any of the PWID locations, but was reportedly avail-
able nearby (i.e. could be purchased from a pharmacy or
drug dealer) at six locations. Sex work occurred at just
less than half (42%, 15/36) of the locations, and drug
sales occurred at about three quarters (72%, 26/36) of
the locations. Most PWID (83%, 30/36) identified local
health facilities. Almost all PWID (92%, 33/36) identified
local pharmacies where needles and syringes could be
purchased. Two-thirds (69%, 25/36) of PWID identified
locations where condoms were accessible. A quarter of
PWID (25%, 9/36) felt that their health needs were being
met. Discarding used needles and syringes in the rubbish
bin was the most common method of needle and syringe
disposal (44%, 16/36). Most PWID (86%, 31/36) visited
approximately three locations per day. Law enforcement
was the major cause of PWID movement.
Population size estimate
Ten PWID usually congregated at each of the identified
locations at the busiest time. The range of PWID esti-
mated to be accessible in the 12 mapped wards was 568
to 1431 (see Fig. 4).
eThekwini
PWID locations
We interviewed 384 non-drug users (283 males and 101
females) in 15 of eThekwini’s 110 electoral wards. One
ward could not be mapped due to social unrest, which
included violent protests. Ninety PWID locations were
suggested in total. A total of 39 suggested PWID loca-
tions were visited. All PWID who were approached
agreed to participate. Injecting was identified at one of
the 14 non-injecting locations that were visited as part
of the location validation process. Forty interviews (35
male and 5 female PWID) were conducted in total. Most
locations (70%, 28/40) were in public spaces including
on the street, near bridges, parks and public toilets.
Service delivery needs and other location characteristics
Sterile injecting equipment was reportedly available for
purchase at one location and near to six other locations.
Sex work and drug sales occurred at more than half of
the locations (58% (23/40) and 58% (23/40), respect-
ively). All PWID identified local health facilities, and 34
Fig. 3 PWID estimates by data source, 16 electoral wards mapped in Cape Town, 2015
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identified locations where condoms could be accessed.
Almost all PWID (98%, 39/40) identified local phar-
macies where needles and syringes could be pur-
chased. Five PWID felt that their health needs were
being met. Discarding used injecting equipment into
the rubbish bin was the most common method of
disposal (50%, 20/40). Most (83%, 33/40) PWID vis-
ited approximately three PWID locations per day.
Most PWID moved for drug-related reasons (i.e. to
purchase drugs or to conduct activities (e.g., begging,
doing casual jobs) to obtain money to be able to
acquire drugs).
Population size estimate
Six PWID usually congregated at each of the PWID loca-
tions at the busiest time. The range of PWID estimated to
be accessible in the 15 mapped was 184–350 (see Fig. 5).
Discussion
This is the first study that maps locations where PWID
congregate in three of South Africa’s major cities. In gen-
eral, secondary key informants were not able to identify
locations where injecting took place, either overestimating
the number of locations where injecting occurred or not
being aware of other locations where PWID congregate.
Fig. 4 PWID estimates by data source, 12 electoral wards mapped in Tshwane, 2015
Fig. 5 PWID estimates by data source, 15 electoral wards mapped in eThekwini, 2015
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Our research confirmed injecting drug use at less than
half of the suggested locations. Furthermore, injecting
drug use was confirmed at 4% of locations where second-
ary key informants did not suspect injecting drug use.
Across all cities, PWID were accessible and congregated
in public spaces. This is to be expected and is described in
the literature and ascribed to easy access to both con-
sumers and dealers [28], safety-seeking [28, 29], income
generation [30] and socialisation [29]. The complex nexus
of police action and ability to practice harm reduction in
public spaces has also been described in the literature [31,
32]. Sterile injecting equipment was only available at one
of these locations, highlighting the lack of outreach ser-
vices, which could provide education, agency development
and harm reduction equipment. Previous research among
PWID in these cities found that half of PWID reused their
injecting equipment the last time they injected and more
than half had ever shared injecting equipment with some-
one else [17]. The limited access to injecting equipment is
likely to be a contributing factor for needle and syringe re-
use and sharing in these cities.
Although most PWID knew where their local clinic was
located, or where needles and syringes could be pur-
chased, only a third felt that their health needs were being
met. This finding is unsurprising as HIV prevention and
outreach have not focused on PWID in either Tshwane or
eThekwini during the time the study took place, and a
short-term harm reduction programme for men who have
sex with men that included a needle and syringe compo-
nent was provided in Cape Town [23].
Sex work and drug sales commonly occurred at about
two-thirds of the locations where PWID congregate.
Previous studies among PWID in South Africa have
identified sex work among PWID, particularly among fe-
male PWID [17, 33, 34]. The intersection between drug
use and sex work is important from an HIV point of view,
which service providers should consider when planning
services. This study did not assess PWID’s engagement in
sex work.
Few female PWID were recruited as part of the assess-
ment. This recruitment pattern reflects previous South
African studies that have also suggested that women who
inject drugs face additional stigma and discrimination and
that their specific health and social needs have not been
met [17, 35].
The PWID in these cities are mobile, with movements
often influenced by their engagement with law enforce-
ment officers. This finding confirms similar reports noting
the need to improve relationships between PWID and law
enforcement officers, with a move away from criminalis-
ing people who use drugs [36–39] and exploring options
of police assisted referral to harm reduction services [40].
International data from various settings highlights that
fear of and experienced negative engagement with police
contributes to rushed and unsafe injecting practices [30,
41–44]. The role of private security, who play an integral
part of South Africa’s security sector, has also been de-
scribed as having a negative impact on access to health
services and the rights of PWID [45]. Local data describ-
ing and quantifying the contribution of law enforcement
on injecting-related risk among PWID in South Africa is
limited. However, this study notes that engagement
between PWID, law enforcement, mobility, and related
risk are core considerations when designing services for
PWID. International experience has shown that an enab-
ling environment for improved public health is possible
through partnerships with police [46–48].
In addition to limited access to injecting equipment and
frequent encounters with police, PWID at these locations
reported unsafe needle and syringe disposal practices.
Many PWID disposed of used injecting equipment in ways
that they thought were safe (e.g. breaking off needles).
However, many PWID reported disposing needles in gar-
bage collection facilities or in public spaces. This finding
is not surprising given the absence of needle and syringe
programmes or other systems for the safe disposal of
sharps in these cities. Creating mechanisms for safe dis-
posal of injecting equipment should also be a core elem-
ent of needle and syringe programmes, which would be
more effective with police support [49].
The methods we used in this study provided insights
into locations where PWID congregate and what services
are needed and highlighted important considerations
when planning services for PWID. Security threats and
the clandestine nature of PWID networks were challenges
that we needed to overcome to complete the study, and
these same challenges could be considered when planning
HIV prevention and related services for PWID.
Reflection on the study teams’ experience of the for-
mative assessment highlighted critical issues that should
be considered when designing PWID services. Several
team members reported the assessment as being an
emotionally challenging experience; many felt nega-
tively affected by their exposure to the high burden of
social and health issues experienced by PWID in the
mapped areas. Fieldwork teams found that the process
was an invaluable step towards initiating relationships
with PWID and developing the requisite skills for en-
gaging with PWID. Team leaders found the experience
useful in building their skills to implement HIV preven-
tion interventions for PWID in challenging environ-
ments. During implementation, the study managers
were frequently required to provide emotional and pro-
fessional support to fieldworkers, some of whom cur-
rently or previously used drugs. The involvement of
PWID (as fieldworkers and in CAGs and other consul-
tations) increased levels of trust and access to a broader
network of PWID, highlighting the importance of
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participatory planning and implementation of studies
or services.
Limitations
The assessment was not designed to assess risk prac-
tices or uptake of health services. Neither did the as-
sessment differentiate between locations where PWID
injected drugs or where they engaged in other activities.
Challenges in measuring PWID mobility and reliance
on “wisdom of the crowd” and “consensus” methods
limit the robustness of our PWID size estimates. The
potential extrapolation of the estimates to other areas
with similar characteristics is limited, as we used non-
random sampling techniques. Furthermore, contextual
factors (e.g. drug availability, concentration of people,
other factors contributing to movement and law en-
forcement activity) [50] influence drug use, and as such
would influence injecting drug use location(s) in other
wards and/or cities.
Conclusions
Despite being restricted to a small number of wards in
three cities, this study confirms that PWID are access-
ible, facing huge challenges to HIV prevention and are
in need of increased attention, financing and support.
Structured formative assessments are useful to system-
atically map locations where PWID congregate, assess
the availability of HIV prevention and health services,
assess mobility and document experiences of law en-
forcement engagement. General community members
(secondary key informants) who do not inject drugs do
not have a good understanding of where injecting drug
use takes place or where PWID are accessible. Formative
assessments deepen the understanding of the injecting
drug use context and provide an opportunity to establish
trusting relationships with the PWID community and
other stakeholders. The activities also build skills that
service providers need to be able to effectively engage
with and provide services to PWID—an essential pre-
paratory step for service delivery.
This study provides the first local level size estimates of
PWID in these cities. The range of estimates derived from
the various methods used was wide but the use of many
methods and inclusion of PWID community members
may have increased the reliability of these estimates. In
contrast to the service delivery data, other methods re-
sulted in lower numbers of PWID for the selected wards.
This could be linked to movement of PWID to locations
where sterile injecting equipment was being provided
(including PWID who congregate in public spaces outside
of the mapped wards or who do not congregate with other
PWID in public spaces), people transitioning to injecting,
or other factors that need to be identified.
Recommendations
Future formative assessments that make use of program-
matic mapping techniques should consider focusing
more on obtaining information from people who use
drugs from the onset. Fieldwork teams should include
people who currently or who have used or injected drugs
to increase the efficiency of the formative assessment
process. The provision of sterile injecting equipment
along with brief harm reduction messaging should be
considered for future formative assessments to increase
the value of participation for PWID. Researchers and
project planners embarking on formative assessments
should consider classification of PWID locations, includ-
ing locations where injecting occurs, and additional ef-
forts to recruit females who inject drugs.
HIV prevention commodities, specifically sterile inject-
ing equipment, and mechanisms for the safe disposal of
used injecting equipment should be provided in the loca-
tions where PWID congregate or in locations where
PWID can be accessed in Cape Town, Tshwane and
eThekwini. Additional information on locations where fe-
males who inject drugs can be accessed to provide HIV
prevention and harm reduction services in these cities is
still needed. Considering the mobile nature of the PWID
community, HIV prevention and harm reduction pro-
grammes should be flexible and delivered by mobile ser-
vices and through peers to adapt to multiple service
delivery routes in accordance with the mobile nature of
PWID. Human rights violations should be documented as
part of HIV prevention and harm reduction programmes
to understand the impact on uptake of HIV prevention
and harm reduction services by PWID and the concomi-
tant health consequences thereof. Ward-based size esti-
mates generated from formative assessments should be
used as baseline estimates and for target setting for HIV
prevention and harm reduction programming.
Endnotes
1Exchange rate on 8 April 2017.
2Validation was done at 10% of non-injecting locations
in wards with less than five PWID locations and 5% of
non-injecting locations in wards with five or more
PWID
3Service delivery commenced in June 2015, before data
cleaning and analysis of the formative assessment was
complete. As such, service delivery data from each city be-
came available for comparison against the other estimates.
Abbreviations
CAG: Community advisory group; GPS: Global positioning system;
HIV: Human immunodeficiency virus; LI: Location identification; LV: Location
verification; OST: Opioid substitution therapy; PEPFAR: United States’
President’s Emergency Plan for AIDS Relief; PWID: People who inject drugs;
UNAIDS: Joint United Nations Program on HIV and AIDS; UNODC: United
Nations Office on Drugs and Crime; WHO: World Health Organization;
ZAR: South African Rand
Scheibe et al. Harm Reduction Journal  (2017) 14:35 Page 10 of 12
Acknowledgements
Participants that took part in the study were as follows: Members of the Step
Up team, staff from participating organisations and PWID community
members including Catherine Williams, Felix Grove, Mawethu Ndaba,
Moenier Petersen, Eugene Beukes, Cebisa Gola, Linda Sambata, Sedick Harris,
Bradley Dreyden, Belinda Cloete, James Mandean., Ismail Mohammed, Gillian,
Munnik, Ian Robert, Broughton, Leigh Wentzel, Yaseen, Mogamat Casiem,
Virgil, Eric Dube, Esau Selomane, Igsaan Harris, Thobeka, Shafiek Scharneck,
Ryan Fillies, Yangama Doda, Andile Feni, Antonio, Ridhaa Fillies, Ayanda
Denge, Mandla Nyakatya, Iris van der Schuur, Leigh Wentzel, Dawie Nel,
Henri Bam, Derick Louw, Angela McBride, Avri Spilka, Urell Oliver, Karabo
Moagi, Victor, Christo, Shaun, Moses, Jacques, Robin Ogle, Zara Von
Homeyer, Kenneth Louw, Anwar Marescia, Nikiwe Murondere, Delia
Scheepers, Lucky Ndlovu, Ashley Ramsarup, Wayne Bauer, Kombo, Senzo,
Toyse Mbongwa, Swelihle Nyawose and Peggy Modikoe. Additional thanks
goes to the people from the organisations that supported the development
and implementation of the study including Alina Bocai and Jason Eligh
(United Nations Office on Drugs and Crime), Janine Wildshut and Machteld
Busz (Mainline), Richard Needle and Gillian Miles (United States Centers
for Disease Control and Prevention, Atlanta), Faran Emmanual (University
of Manitoba), Sharon Stucker Weir (University of North Carolina Chapel
Hill) and Udak Daniel (Nigerian National Agency for the Control of AIDS).
Availability of data and materials
The datasets generated during the current study are not publicly available
due to the sensitive nature of the information collected, in particular, the
coordinates of locations where PWID congregate. However, de-indentified
data may be made available on request.
Funding
Funding was provided by the President’s Emergency Plan for AIDS Relief
(PEPFAR) through a cooperative agreement (GH000257) with the Centers
for Disease Control and Prevention (CDC). The findings and conclusions in
this report are those of the authors and do not necessarily represent the
views of the Centers for Disease Control and Prevention.
Authors’ contributions
AS, AL, HS and HH developed and refined the protocol. RB, AS and NM
oversaw the implementation and data entry; AS led the data analysis,
and all authors read and approved the draft and final manuscripts.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
All participants provided verbal informed consent to participate in this study.
Study approval was received from the University of the Western Cape, the
KwaZulu-Natal Department of Health ethics committee and the United
States Centers for Disease Control and Prevention.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1TB/HIV Care Association, Cape Town, South Africa. 2Desmond Tutu HIV
Centre, Cape Town, South Africa. 3OUT LGBT Wellbeing, Pretoria, South
Africa. 4United States Centers for Disease Control and Prevention, Pretoria,
South Africa. 5School of Public Health, University of the Western Cape, Cape
Town, South Africa. 6Department of Psychiatry and Mental Health, University
of Cape Town, Cape Town, South Africa.
Received: 8 April 2017 Accepted: 30 May 2017
References
1. National Department of Health, KwaZulu Natal Provincial Government,
Central Drug Authority, UNODC, CDC, TB HIV Care Association, et al. After
30 years the time for dealing with injecting drug use has finally come.
Report from the Drug Use and HIV Preconference. Durban: National
Department of Health, KwaZulu Natal Provincial Government, Central Drug
Authority, UNODC, CDC, TB HIV Care Association; 2015.
2. UNAIDS. UNAIDS Terminology Guidelines. Geneva: UNAIDS; 2015.
3. Rhodes T, Lowndes C, Judd A, Mikhailova LA, Sarang A, Rylkov A, et al.
Explosive spread and high prevalence of HIV infection among injecting
drug users in Togliatti City, Russia. AIDS [Internet]. 2002;16:F25–31. Available
from: http://www.ncbi.nlm.nih.gov/pubmed/12218407.
4. Conrad C, Bradley HM, Broz D, Buddha S, Chapman EL, Galang RR, et al.
Community outbreak of HIV infection linked to injection drug use of
oxymorphone—Indiana, 2015. Mmwr. 2015;64:443–4.
5. Strathdee SA, Sherman SG. The role of sexual transmission of HIV
infection among injection and non-injection drug users. J Urban Health
[Internet]. 2003;80:iii7–14. Available from: http://www.pubmedcentral.nih.
gov/articlerender.fcgi?artid=3456264&tool=pmcentrez&rendertype=
abstract.
6. Degenhardt L, Mathers B, Guarinieri M, Panda S, Phillips B, Strathdee S,
et al. The global epidemiology of methamphetamine injection. A
review of the evidence on use and associations with HIV and other
harm. NDARC: Sydney; 2007.
7. Global Commission on HIV and the Law. Global Commission on HIV and
the Law. Risks, rights and health. Final Rep. New York: UNDP, HIV/AIDS
Group; 2012.
8. Gupta GR, Parkhurst JO, Ogden JA, Aggleton P, Mahal A. Structural
approaches to HIV prevention. Lancet [Internet]. 2008;372:764–75. Available
from: http://www.ncbi.nlm.nih.gov/pubmed/18687460.
9. Asher AK, Hahn J a, Couture M-C, Maher K, Page K. People who Inject
Drugs, HIV Risk, and HIV Testing Uptake in Sub-Saharan Africa. J. Assoc.
Nurses AIDS Care [Internet]. 2012 [cited 2013 Sep 14];1–10. Elsevier Ltd,
Available from: http://www.ncbi.nlm.nih.gov/pubmed/23164598.
10. Degenhardt L, Mathers B, Vickerman P, Rhodes T, Latkin C, Hickman M.
Prevention of HIV infection for people who inject drugs: why individual,
structural, and combination approaches are needed. Lancet [Internet]. 2010;
376:285–301. Elsevier Ltd, Available from: http://www.ncbi.nlm.nih.gov/
pubmed/20650522, [cited 2012 Mar 14].
11. UNODC. World Drug Report. Vienna: UNODC; 2016.
12. Petersen Z, Myers B, van Hout M-C, Plüddemann A, Parry C. Availability of
HIV prevention and treatment services for people who inject drugs: findings
from 21 countries. Harm Reduct J. [Internet]. 2013 [cited 2013 Aug 26];10:13.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/23957896.
13. World Health Organization, UNAIDS, United Nations Office on Drugs and
Crime. Policy Brief: Provision of sterile injecting equipment to reduce HIV
transmission. Geneva: World Health Organization; 2004.
14. Dos Santos M, Trautmann F, Kools JP. Rapid assessment response study:
drug use and health risk—Pretoria, South Africa. Harm Reduct J. 2011;8:14.
15. Parry CDH, Pithey AL. Risk behaviour and HIV among drug using
populations in South Africa. Afr J Drug Alcohol Stud. 2006;5:140–57.
16. Plüddemann A, Parry CDH, Flisher AJ, Jordaan E. Heroin users in Cape Town,
South Africa: injecting practices, HIV-related risk behaviors, and other health
consequences. J Psychoactive Drugs [Internet]. 2008;40:273–9. Available
from: http://www.ncbi.nlm.nih.gov/pubmed/19004419.
17. Scheibe A, Makapela D, Brown B, dos Santos M, Hariga F, Virk H, et al. HIV
prevalence and risk among people who inject drugs in five South African
cities. Int J Drug Policy. 2016;30:107–15. Elsevier B.V., Available from: http://
linkinghub.elsevier.com/retrieve/pii/S095539591600027X.
18. Desmond Tutu HIV Foundation. Key Populations, Key Solutions. A Gap
Analysis for Key Populations and HIV in South Africa. Report. Pretoria: South
African National AIDS Council; 2011.
19. Weich L. “ Defeating the dragon ”—can we afford not to treat patients with
heroin dependence? South African J Psychiatry. 2010;16:75–9.
20. Myers BJ, Louw J, Pasche SC. Inequitable access to substance abuse
treatment services in Cape Town, South Africa. Subst Abuse Treat Prev
Policy. 2010;5:28.
21. S H. The Sultan Bahu Opioid Substitution Program within the Auspices of
Community Based Services. Implementation 2015/16. Presentation. South
Africa Drug Policy Week. Cape Town: Sultan Bahu; 2016.
22. Harm Reduction International. The Global State of Harm reduction. 2012.
London: Harm Reduction International; 2012.
23. Harm Reduction International. The Global State of Harm Reduction 2014.
London: Harm Reduction International; 2014.
Scheibe et al. Harm Reduction Journal  (2017) 14:35 Page 11 of 12
24. Weir S, Blanchard J, Garcia Calleja J, Sabin K, Ghys P, Abdul-Quader A, et al.
Programmatic Mapping and Size Estimation Draft Protocol. MEASURE
Evaluation: Chapel Hill; 2014.
25. Municipal Demarcation Board. Ward deliminations [Internet]. 2016 [cited
2016 Sep 5]. Available from: http://www.demarcation.org.za/site/.
26. Okal J, Geibel S, Muraguri N, Musyoki H, Tun W, Broz D, et al. Estimates of
the size of key populations at risk for HIV infection: men who have sex with
men, female sex workers and injecting drug users in Nairobi, Kenya. Sex
Transm Infect. [Internet]. 2013 [cited 2013 Sep 9];366–71. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/23761166.
27. Wazimap. Wazibap South Africa [Internet]. 2016 [cited 2016 Sep 5]. Available
from: http://wazimap.co.za.
28. Dovey K, Fitzgerald J, Choi Y. Safety becomes danger: dilemmas of drug-use
in public space. Heal Place. 2001;7:319–31.
29. Fast D, Shoveller J, Shannon K, Kerr T. Safety and danger in downtown
Vancouver: understandings of place among young people entrenched in an
urban drug scene. Heal Place. 2010;16:51–60.
30. Jozaghi E. “The biggest mistake God ever made was to create junkies”:
unsafe injection practices, health care discrimination and overdose deaths
in Montreal, Canada. Can Grad J Sociol Criminol. 2012;2:20.
31. Burris S, Blankenship KM, Donoghoe M, Sherman S, Vernick JS, Case P, et al.
Addressing the “risk environment” for injection drug users: the mysterious
case of the missing cop. Milbank Q. 2004;82:125–56. Available from: http://
www.ncbi.nlm.nih.gov/pubmed/15016246.
32. Rhodes T, Kimber J, Small W, Fitzgerald J, Kerr T, Hickman M, et al. Public
injecting and the need for “safer environment interventions” in the
reduction of drug-related harm. Addiction. 2006;101:1384–93.
33. Needle R, Kroeger K, Belani H, Achrekar A, Parry CD, Dewing S. Sex, drugs,
and HIV: rapid assessment of HIV risk behaviors among street-based drug
using sex workers in Durban, South Africa. Soc Sci Med [Internet]. 2008
[cited 2011 Feb 7];67:1447–55. Available from: http://www.ncbi.nlm.nih.gov/
pubmed/18678437.
34. Parry CDH, Carney T, Petersen P, Dewing S, Needle R. HIV-risk behavior among
injecting or non-injecting drug users in Cape Town, Pretoria, and Durban,
South Africa. Subst Use Misuse. 2009;44:886–904. Available from: http://www.
ncbi.nlm.nih.gov/pubmed/19444728.
35. Parry C, Petersen P, Dewing S, Carney T, Needle R, Kroeger K, et al. Rapid
assessment of drug-related HIV risk among men who have sex with men in
three South African cities. Drug Alcohol Depend [Internet]. 2008;95:45–53.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/18242881,
[cited 2011 Feb 9].
36. UNODC. National PWID community consultation. Report. UNODC: Cape
Town; 2014.
37. Scheibe A, Richter M, Vearey J. Sex work and South Africa’s health system:
addressing the needs of the underserved. South African Health Review.
2016;19(1):165–78.
38. Step Up Project, TB HIV Care Association, Mainline, OUT LGBT Wellbeing.
Human Rights Report. 15 August to 15 November 2015. Cape Town: TB HIV
Care Association; 2015.
39. Marks M, Howell S. Cops, drugs and interloping academics : An
ethnographic justification for harm reduction-based programmes in South
Africa. Police Pract. Res. 2015;4263.
40. Landsberg A, Kerr T, Milloy MJ, Dong H, Nguyen P, Wood E, et al. Declining
trends in exposures to harmful policing among people who inject drugs in
Vancouver, Canada. J Int AIDS Soc [Internet]. 2016;19(Suppl 3):20729.
Available from: http://www.jiasociety.org/index.php/jias/article/view/20729.
41. Lunze K, Lunze FI, Raj A, Samet JH, Cepeda J, Odinokova V, et al. Stigma
and Human Rights Abuses against People Who Inject Drugs in Russia—A
Qualitative Investigation to Inform Policy and Public Health Strategies. Meier
BM, editor. PLoS One. Public Library of Science; 2015;10:e0136030
42. Ti L, Hayashi K, Kaplan K, Suwannawong P, Wood E, Kerr T. Contextual
factors associated with rushed injecting among people who inject drugs in
Thailand. Prev Sci Springer US. 2015;16:313–20.
43. Small W, Kerr T, Charette J, Schechter MT, Spittal PM. Impacts of intensified
police activity on injection drug users: evidence from an ethnographic
investigation. Int J Drug Policy. 2006;17:85–95.
44. Žikić B. Injecting Drug Users ’ Utilisation of Public Space in Belgrade : Places, Risk-
management, and Habitual. Eтнoгpaфcки инcтитут CAHУ. 2006;83:189–90
45. Markwick N, McNeil R, Small W, Kerr T. Exploring the public health impacts
of private security guards on people who use drugs: a qualitative study.
J Urban Heal. 2015;92:1117–30.
46. Sharma M, Chatterjee A. Partnering with law enforcement to deliver good
public health: the experience of the HIV/AIDS Asia regional program. Harm
Reduct J. 2012;9:24.
47. Cloud D, Davis C. First Do No Harm: Advancing Public Health in Policing
Practices. New York: Vera Institute of Justice; 2015.
48. Stevens A. Applying harm reduction principles to the policing of retail drug
markets. Modernising Drug Law Enforcement. Report 3. London: IDPC; 2013.
49. Scheibe A, Naude N, Marks M, Patterson D, Thomson N. Enhancing
Partnerships Between Law Enforcement, Criminal Justice and HIV
Programmes Working with Key Populations: Opportunities in South Africa.
Round table meeting report. Geneva: International AIDS Society; 2016.
50. Strathdee SA, Hallett TB, Bobrova N, Rhodes T, Booth R, Abdool R, et al. HIV
and risk environment for injecting drug users: the past, present, and future.
Lancet [Internet]. 2010;376:268–84. Available from: http://www.ncbi.nlm.nih.
gov/pubmed/20650523, [cited 2012 Mar 9].
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Scheibe et al. Harm Reduction Journal  (2017) 14:35 Page 12 of 12
